4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-033408
Chief Financial Officer sold 2,084 shares at $19.50 ($40,638)
- Chief Financial Officer acquired 2,084 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Steinhart Richard I · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-14 | Exercise or conversion : show line 1 in the form | +2,084 | 3,584 | D | ||
| 2023-03-15 | Sale : show line 2 in the form | −2,084 | $19.50 | $40,638 | 1,500 | D |
| Open-market sales · 2,084 sh · avg $19.50 · $40,638 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-14 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,084 | 6,253 | D |
| 2023-03-15 | Grant or award : show line 4 in the form Restricted Stock Units | +9,000 | 9,000 | D |
| 2023-03-15 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +32,000 | 32,000 | D |
Loading xslF345X03/tm239796-6_4seq1.xml…